Mario Alberto Accardi sold $300K of Centessa Pharmaceuticals (CNTA)

Executed Dec 8 2025, disclosed Dec 8 2025, the same day.

Value, as filed

$300K

10,000 sh × $30.00

Executed

Dec 8 2025

the trade date, as filed

Disclosed

Dec 8 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MA Mario Alberto Accardi President, Orexin Program profile →

Mario Alberto Accardi (President, Orexin Program) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Centessa Pharmaceuticals plc (CNTA). The largest single filing was $300K of CNTA (10,000 sh × $30.00, as filed), executed Dec 8 2025.

The name

CNTA Centessa Pharmaceuticals plc CNTA · Healthcare · 56 filings in 24 months ticker →

Healthcare · Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in t…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Mario Alberto Accardi in CNTA

CNTASALE Centessa Pharmaceuticals plc $213K
7,432 sh × $28.70
Exec Dec 9 2025
Filed Dec 9 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc $200K
8,000 sh × $25.00
Exec Oct 27 2025
Filed Oct 27 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc $158K
7,430 sh × $21.33
Exec Sep 16 2025
Filed Sep 16 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc $140K
7,000 sh × $20.00
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc $127K
8,322 sh × $15.23
Exec Jul 29 2025
Filed Jul 30 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc $210K
15,000 sh × $14.00
Exec Jun 24 2025
Filed Jun 25 2025 · 5:30 PM ET